Denglei Ma

444 total citations
23 papers, 335 citations indexed

About

Denglei Ma is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Denglei Ma has authored 23 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 7 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Denglei Ma's work include Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Alzheimer's disease research and treatments (7 papers) and Neurological Disease Mechanisms and Treatments (6 papers). Denglei Ma is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Alzheimer's disease research and treatments (7 papers) and Neurological Disease Mechanisms and Treatments (6 papers). Denglei Ma collaborates with scholars based in China, United States and Canada. Denglei Ma's co-authors include Lin Li, Lan Zhang, Li Zhang, Yali Li, Mingyang Wang, Lan Zhang, Hongwei Tan, Mengchao Cui, Kan Wang and Yi Liang and has published in prestigious journals such as Nature Communications, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Denglei Ma

23 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denglei Ma China 13 128 106 82 41 40 23 335
Valencia Fernandes India 12 160 1.3× 105 1.0× 82 1.0× 49 1.2× 34 0.8× 20 399
Fuxing Dong China 16 268 2.1× 73 0.7× 96 1.2× 55 1.3× 25 0.6× 32 580
Liangfeng Liu Hong Kong 8 146 1.1× 109 1.0× 40 0.5× 27 0.7× 55 1.4× 8 384
Ian Gurrell United Kingdom 11 176 1.4× 96 0.9× 39 0.5× 47 1.1× 63 1.6× 14 402
Yunqing Ma China 11 169 1.3× 69 0.7× 38 0.5× 39 1.0× 15 0.4× 27 426
Minghui Jessica Chen Singapore 11 194 1.5× 83 0.8× 51 0.6× 50 1.2× 24 0.6× 15 437
Jinghan Feng China 7 160 1.3× 48 0.5× 135 1.6× 20 0.5× 19 0.5× 8 355
Min Xie China 13 223 1.7× 120 1.1× 25 0.3× 34 0.8× 18 0.5× 38 453
Guangying Du China 13 174 1.4× 25 0.2× 41 0.5× 33 0.8× 24 0.6× 31 434
Silvia Piccirillo Italy 13 207 1.6× 74 0.7× 53 0.6× 169 4.1× 23 0.6× 27 404

Countries citing papers authored by Denglei Ma

Since Specialization
Citations

This map shows the geographic impact of Denglei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denglei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denglei Ma more than expected).

Fields of papers citing papers by Denglei Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denglei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denglei Ma. The network helps show where Denglei Ma may publish in the future.

Co-authorship network of co-authors of Denglei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Denglei Ma. A scholar is included among the top collaborators of Denglei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denglei Ma. Denglei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Qing, Denglei Ma, В. Н. Ильин, et al.. (2024). A human Tau expressing zebrafish model of progressive supranuclear palsy identifies Brd4 as a regulator of microglial synaptic elimination. Nature Communications. 15(1). 8195–8195. 3 indexed citations
2.
Ma, Denglei, Lihong Gu, Yali Li, et al.. (2024). Epimedium flavonoids improve cerebral white matter lesions by inhibiting neuroinflammation and activating neurotrophic factor signal pathways in spontaneously hypertensive rats. International Immunopharmacology. 139. 112683–112683. 4 indexed citations
3.
Ma, Denglei, et al.. (2023). Icariin Inhibits Overexpression and Aggregation of α-Synuclein in A53T α-Synuclein Transgenic Mice by Regulating Parkin and PLK2. Journal of Integrative Neuroscience. 22(6). 166–166. 2 indexed citations
4.
Ma, Denglei, et al.. (2021). Cornel Iridoid Glycoside Ameliorated Alzheimer’s Disease-Like Pathologies and Necroptosis through RIPK1/MLKL Pathway in Young and Aged SAMP8 Mice. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 11 indexed citations
5.
Ma, Denglei, Mingyang Wang, Cuicui Yang, et al.. (2021). Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801. Brain Research Bulletin. 174. 141–152. 15 indexed citations
6.
Ma, Denglei, Rui Huang, Kaiwen Guo, et al.. (2021). Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing N-Methyl-D-aspartate Receptor Expression in a Tau Transgenic Mice. Frontiers in Aging Neuroscience. 13. 671206–671206. 8 indexed citations
7.
Ma, Denglei, et al.. (2021). Progress in the Application of Drugs for the Treatment of Multiple Sclerosis. Frontiers in Pharmacology. 12. 724718–724718. 33 indexed citations
8.
Wu, Pengfei, et al.. (2021). Growth Factors and Their Roles in Multiple Sclerosis Risk. Frontiers in Immunology. 12. 768682–768682. 8 indexed citations
9.
Ma, Denglei, et al.. (2021). Icariin Promotes Survival, Proliferation, and Differentiation of Neural Stem Cells In Vitro and in a Rat Model of Alzheimer’s Disease. Stem Cells International. 2021. 1–12. 17 indexed citations
10.
11.
12.
Niu, Hongmei, Denglei Ma, Mingyang Wang, et al.. (2020). Epimedium flavonoids protect neurons and synapses in the brain via activating NRG1/ErbB4 and BDNF/Fyn signaling pathways in a chronic cerebral hypoperfusion rat model. Brain Research Bulletin. 162. 132–140. 23 indexed citations
13.
Ma, Denglei, Yi Luo, Zirun Zhao, et al.. (2020). Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction. Current Medical Science. 40(6). 1031–1039. 13 indexed citations
14.
Zhou, Kaixiang, Chang Yuan, Bin Dai, et al.. (2019). Environment-Sensitive Near-Infrared Probe for Fluorescent Discrimination of Aβ and Tau Fibrils in AD Brain. Journal of Medicinal Chemistry. 62(14). 6694–6704. 60 indexed citations
15.
Ma, Denglei, Na Wang, Xiaotong Fan, et al.. (2018). Protective Effects of Cornel Iridoid Glycoside in Rats After Traumatic Brain Injury. Neurochemical Research. 43(4). 959–971. 25 indexed citations
16.
Gu, Jianlan, Nana Jin, Denglei Ma, et al.. (2018). Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer’s Disease Brain. Journal of Alzheimer s Disease. 62(4). 1737–1746. 22 indexed citations
17.
Jin, Nana, Denglei Ma, Jianlan Gu, et al.. (2018). O-GlcNAcylation modulates PKA-CREB signaling in a manner specific to PKA catalytic subunit isoforms. Biochemical and Biophysical Research Communications. 497(1). 194–199. 13 indexed citations
18.
Ma, Denglei, et al.. (2018). CIG suppresses tau pathology in a mouse model of tauopathy through regulating the activity of PP2A. Proceedings for Annual Meeting of The Japanese Pharmacological Society. WCP2018(0). PO4–8. 1 indexed citations
19.
Ma, Denglei, et al.. (2016). Beneficial effects of cornel iridoid glycoside on behavioral impairment and senescence status in SAMP8 mice at different ages. Behavioural Brain Research. 312. 20–29. 18 indexed citations
20.
Tang, Wenjing, Denglei Ma, Cuicui Yang, et al.. (2016). Cornel Iridoid Glycoside Improves Locomotor Impairment and Decreases Spinal Cord Damage in Rats. BioMed Research International. 2016. 1–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valencia Fernandes Breakdown of academic impact, for papers by Fuxing Dong Breakdown of academic impact, for papers by Liangfeng Liu Breakdown of academic impact, for papers by Ian Gurrell Breakdown of academic impact, for papers by Yunqing Ma Breakdown of academic impact, for papers by Minghui Jessica Chen Breakdown of academic impact, for papers by Jinghan Feng Breakdown of academic impact, for papers by Min Xie Breakdown of academic impact, for papers by Guangying Du Breakdown of academic impact, for papers by Silvia Piccirillo
Rankless by CCL
2026